Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial

…, S Hoover, J Kiluk, C Laronga, M Rosa… - Nature Medicine, 2023 - nature.com
Talimogene laherparepvec (T-VEC) is an oncolytic virus hypothesized to enhance triple-negative
breast cancer (TNBC) responses to neoadjuvant chemotherapy (NAC). This article …

Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor

J Saremian, M Rosa - Archives of Pathology & Laboratory …, 2012 - meridian.allenpress.com
Solid papillary carcinomas are tumors morphologically characterized by round, well-defined
nodules composed of low-grade ductal cells separated by fibrovascular cores. These …

The value of fine needle aspiration biopsy in the diagnosis and prognostic assessment of palpable breast lesions

M Rosa, A Mohammadi, S Masood - Diagnostic Cytopathology, 2012 - Wiley Online Library
In recent years there appears to be a growing movement toward the use of core needle
biopsy (CNB) over fine needle aspiration biopsy (FNAB) for the detection of breast carcinoma. …

Male breast: clinical and imaging evaluations of benign and malignant entities with histologic correlation

A Chau, N Jafarian, M Rosa - The American Journal of Medicine, 2016 - Elsevier
Breast cancer is an uncommon disease in men. As a result, the diagnosis may not initially
be considered. Understanding the common benign and malignant entities affecting the male …

Radiation-associated angiosarcoma of the breast: clinical and pathologic features

S Shah, M Rosa - Archives of pathology & laboratory …, 2016 - meridian.allenpress.com
Breast angiosarcoma is an unusual malignancy accounting for approximately 1% of soft
tissue sarcomas. It can occur as a primary form without a known precursor or as a secondary …

Borderline breast lesions: diagnostic challenges and clinical implications

S Masood, M Rosa - Advances in Anatomic Pathology, 2011 - journals.lww.com
Breast cancer remains a global public health problem and is currently the most polarized
cancer in the world. Attention to this disease, public awareness, and advances in breast …

A phase I trial of talimogene laherparepvec in combination with neoadjuvant chemotherapy for the treatment of nonmetastatic triple-negative breast cancer

…, RJ Weinfurtner, S Hoover, J Kiluk, M Rosa… - Clinical Cancer …, 2021 - AACR
Purpose: Talimogene laherparepvec (TVEC) is an oncolytic herpes simplex 1 virus approved
for treatment of melanoma. We hypothesized intratumoral TVEC may enhance response to …

Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma

D Butler, M Rosa - Archives of Pathology and Laboratory …, 2013 - meridian.allenpress.com
Pleomorphic lobular carcinoma is an uncommon variant of lobular carcinoma, characterized
by significant cytologic atypia that contrasts with the low pleomorphism of classical lobular …

An unusual case of primary small cell neuroendocrine carcinoma of the breast

N Latif, M Rosa, L Samian, F Rana - The breast journal, 2010 - Wiley Online Library
Primary small cell neuroendocrine carcinoma of breast is a rare entity, with only case reports
in literature. Histologically, these tumors are similar to small cell carcinoma of the lung with …

Advances in the molecular analysis of breast cancer: pathway toward personalized medicine

M Rosa - Cancer Control, 2015 - journals.sagepub.com
Background Breast cancer is a heterogeneous disease that encompasses a wide range of
clinical behaviors and histological and molecular variants. It is the most common type of …